Abstract
Candida species are yeast normally present as commensals in the human gastrointestinal and genitourinary tract. Depending on the immune status of the host, Candida species infections can cause a wide spectrum of diseases ranging from local infections to disseminated disease. Local infections in an immunocompetent host typically involve the skin and mucus membranes. Invasive candidiasis can occur in immunocompromised patients, disseminating hematogenously to other sites causing multiorgan involvement.
Candida albicans is the most common species to cause infection in humans; however, invasive infections caused by Candida species other than albicans are being reported with increasing frequency. The observation is important because several of the emerging non-albicans are resistant to commonly used antifungal medications, and some have proven to be highly virulent. Medically important non-albicans Candida species include C. parapsilosis, C. glabrata, C. krusei, C. lusitaniae, C. tropicalis, and C. auris.
Risk factors for the development of candidiasis include the use of broad-spectrum antibiotics, use of oral or inhaled glucocorticoids, treatment with chemotherapy or radiation therapy for underlying malignancy, diabetes mellitus, neutropenia, and primary or acquired defects in cell-mediated immunity. Neonates, especially those born prematurely and those born with a birth weight of less than 1500 g, are also at high risk for developing candidiasis.
Localized candida infections include oropharyngeal candidiasis (thrush), yeast diaper dermatitis, vulvovaginitis, and balanitis. Invasive candidiasis is a major contributor of morbidity and mortality in hospitalized patients and is currently the second most common cause of central catheter-associated bloodstream infections in the United States. Invasive candidiasis is a leading cause of mortality among patients with cancer and recipients of solid-organ or hematopoietic stem cell transplants.
The diagnosis of candidiasis is based on both clinical and laboratory data. Localized candida infections are most often diagnosed clinically, but when the provider is in doubt, an unstained wet preparation or Gram stain can be performed on a scraping from the lesion. Candida will appear as Gram-positive budding yeasts. Invasive candidiasis is diagnosed using a combination of clinical findings, imaging modalities, blood cultures, tissue cultures, and antigen-based tests.
Several topical, oral, and parenteral antifungal medications are available for the treatment of candida infections. The location and severity of the infection, together with host factors, including the presence or absence of immunosuppression help to guide selection of the optimal antifungal medication and its preferred route of administration.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Marodi L, Korchak HM, Johnston RB Jr. Mechanisms of host defense against Candida species. I. Phagocytosis by monocytes and monocyte-derived macrophages. J Immunol. 1991;146(8):2783–9.
Phan QT, et al. Als3 is a Candida albicans invasin that binds to cadherins and induces endocytosis by host cells. PLoS Biol. 2007;5(3):e64.
Benjamin DK Jr, Garges H, Steinbach WJ. Candida bloodstream infection in neonates. Semin Perinatol. 2003;27(5):375–83.
Dutta A, Palazzi DL. Candida non-albicans versus Candida albicans fungemia in the non-neonatal pediatric population. Pediatr Infect Dis J. 2011;30(8):664–8.
MacDonald L, Baker C, Chenoweth C. Risk factors for candidemia in a children’s hospital. Clin Infect Dis. 1998;26(3):642–5.
Zaoutis T. Candidemia in children. Curr Med Res Opin. 2010;26(7):1761–8.
Chitnis AS, et al. Trends in Candida central line-associated bloodstream infections among NICUs, 1999–2009. Pediatrics. 2012;130(1):e46–52.
Edwards JE Jr. Mandell, Douglas and Bennett’s principles and practice of infectious diseases. 7th ed. Philadelphia: Churchill Livingstone Elseiver; 2010. p. 3225–40.
Book R. Report of the committee on infectious diseases. Elk Grove Village: American Academy of Pediatrics. Committee of Infectious Diseases; 2012.
Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev. 2007;20(1):133–63.
Nucci M, Anaissie E. Revisiting the source of candidemia: skin or gut? Clin Infect Dis. 2001;33(12):1959–67.
Zaoutis TE, et al. Risk factors for disseminated candidiasis in children with candidemia. Pediatr Infect Dis J. 2004;23(7):635–41.
Kaufman D, et al. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med. 2001;345(23):1660–6.
Pappas PG, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62(4):e1–50.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Dutta, A. (2019). Candidiasis. In: Domachowske, J. (eds) Introduction to Clinical Infectious Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-91080-2_31
Download citation
DOI: https://doi.org/10.1007/978-3-319-91080-2_31
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-91079-6
Online ISBN: 978-3-319-91080-2
eBook Packages: MedicineMedicine (R0)